FindTrial
Sign In

EFFICACY OF LOW LEVEL LASER THERAPY, KATUPILA TAILA DRESSING AS STANDALONE THERAPIES AND AS A COMBINATION IN MANAGEMENT OF GRADE 1 AND 2 DIABETIC FOOT ULCER.

A RANDOMIZED OPEN LABEL COMPARATIVE CLINICAL STUDY ON THE EFFICACY OF LOW LEVEL LASER THERAPY, KATUPILA TAILA DRESSING AS STANDALONE THERAPIES AND AS A COMBINATION IN MANAGEMENT OF GRADE 1 AND 2 DIABETIC FOOT ULCER. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106485
Enrollment
45
Registered
2026-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

None listed

Sponsors

Dr Hanvi Patel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects Aged Between 21 to 70 Years, Irrespective Of Gender 2.Diagnosed Cases of Diabetes Mellitus with Controlled or moderately controlled blood sugar levels HbA1c greater than or equal to nine 3.Subjects having maximum ulcer size of 8 cm 4.Subjects with diabetic foot ulcer of Grade 1 and 2, as per the University of Texas Classification of Diabetic Ulcers 5. Subjects willing to give Consent

Exclusion criteria

Exclusion criteria: 1.Subjects with diabetic ulcer - grade 3 (As per University of Texas classification of Diabetic Ulcers) 2. Subjects suffering from infectious disease like HIV, Hepatitis and Tuberculosis or sexually transmitted infections. 3. Subjects suffering from Osteomyelitis. 4. Subjects suffering from immunocompromised diseases.

Design outcomes

Primary

MeasureTime frame
To evaluate the combined efficacy of Low Level Laser Therapy followed by Katupila Taila dressing in wound healing compared to the individual use of LLLT or Katupila Taila dressing in the management of Grade 1 and 2 diabetic foot ulcers based on favourable changes observed in the VAS scale and Bates and Jensen Wound Assessment ToolTimepoint: Total duration of study 35 days Duration of treatment 21 day Assessment will be done on 0, 7th ,14th,21st day Follow up 28th and 35th day—

Secondary

MeasureTime frame
Improved Quality of lifeTimepoint: 0, 7th ,14th,21st day—

Countries

India

Contacts

Public ContactDr Hanvi Patel

Professor And HOD

dr.swetatyagi1882@gmail.com9902521973

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026